Progress in epidermolysis bullosa: genetic classification and clinical implications.
Epidermolysis bullosa (EB), a heterogenous group of genodermatoses, is characterized by fragility and blistering of the skin associated with extracutaneous manifestations. Based on clinical severity, constellation of the phenotypic manifestations, and the level of tissue separation within the cutaneous basement membrane zone (BMZ), EB has been divided into distinct subcategories. Traditionally, these include the simplex, junctional, and dystrophic forms of EB, and recently attention has been drawn to hemidesmosomal variants demonstrating tissue separation at the level of the hemidesmosomes. Specific mutations in ten distinct genes expressed within the cutaneous BMZ have been delineated in >500 families with different variants of EB. The types of mutations, their positions along the affected genes, and their consequences at the mRNA and protein levels provide explanation for the phenotypic variability and genetic heterogeneity of this group of genodermatoses. Elucidation of mutations in different forms of EB has direct translational applications for improved diagnosis and molecularly based classification with prognostic implications as well as for genetic counseling and DNA-based prenatal testing in families with EB.
Department of Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, PA 19107, USA. Jouni.Uitto@jefferson.edu
Jouni
J
Uitto
Gabriele
G
Richard
D001485:Basement Membrane / Q000473:pathology; D004252:DNA Mutational Analysis; D004820:Epidermolysis Bullosa / Q000145:classification* / Q000175:diagnosis / Q000235:genetics* / Q000473:pathology*; D005838:Genotype; D006801:Humans; D007633:Keratins / Q000502:physiology; D008954:Models, Biological; D009154:Mutation / Q000235:genetics; D010641:Phenotype
D007633:Keratins